Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $8.44 +1.28 (+17.88%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$8.51 +0.07 (+0.83%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Avalo Therapeutics Stock Price Performance 5 Day Performance+14.83%1 Month Performance+22.32%3 Month Performance-12.54%6 Month Performance-2.43%Year-To-Date Performance+13.59%1 Year Performance+94.92% Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTX Stock Chart for Saturday, February, 22, 2025 AVTX Chart by TradingView Avalo Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$7.21$8.44+17.14%$8.65$7.3647,862 shs$87.69 million02/20/2025$6.99$7.21+3.08%$7.28$6.8121,443 shs$74.86 million02/19/2025$7.09$6.99-1.41%$7.18$6.8832,596 shs$72.63 million02/18/2025$7.35$7.09-3.54%$7.47$7.0126,566 shs$73.67 million02/17/2025$7.35$7.35$8.00$7.2949,083 shs$76.40 million02/14/2025$7.73$7.35-4.92%$8.00$7.2949,083 shs$76.37 million02/13/2025$7.68$7.73+0.65%$7.91$7.6130,474 shs$80.35 million02/12/2025$7.66$7.68+0.26%$7.97$7.4221,783 shs$79.80 million02/11/2025$7.96$7.66-3.77%$8.11$7.5828,752 shs$79.59 million02/10/2025$8.18$7.96-2.69%$8.18$7.909,170 shs$82.70 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$8.19$8.18-0.12%$8.20$7.7922,978 shs$84.99 million02/06/2025$8.38$8.19-2.27%$8.38$7.9511,978 shs$85.09 million02/05/2025$8.11$8.38+3.33%$8.50$7.9434,992 shs$87.07 million02/04/2025$8.02$8.11+1.12%$8.45$7.9040,067 shs$84.26 million02/03/2025$8.42$8.02-4.75%$8.80$7.8240,933 shs$83.33 million01/31/2025$7.90$8.42+6.58%$8.60$7.9144,386 shs$82.11 million01/30/2025$7.60$7.90+3.95%$8.28$7.3645,761 shs$82.08 million01/29/2025$8.04$7.60-5.47%$8.50$7.4251,332 shs$78.96 million01/28/2025$7.16$8.04+12.29%$8.06$7.0535,881 shs$83.54 million01/27/2025$7.54$7.16-5.04%$8.44$7.0854,561 shs$74.42 million01/24/2025$7.58$7.54-0.53%$7.75$7.27104,595 shs$78.34 million01/23/2025$6.59$7.58+15.02%$7.96$6.50150,053 shs$78.79 million01/22/2025$6.90$6.59-4.49%$6.85$6.5011,071 shs$68.47 million01/21/2025$6.75$6.90+2.22%$7.43$6.7661,116 shs$71.69 million01/20/2025$6.75$6.75$6.83$6.04238,024 shs$70.13 million Related Companies Corvus Pharmaceuticals Stock Chart Prime Medicine Stock Chart Monopar Therapeutics Stock Chart Atyr PHARMA Stock Chart Trevi Therapeutics Stock Chart Allogene Therapeutics Stock Chart COMPASS Pathways Stock Chart Korro Bio Stock Chart Olema Pharmaceuticals Stock Chart Foghorn Therapeutics Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
